UroGen Pharma Ltd (URGN) short volume · rev $109.8M
UroGen Pharma Ltd FINRA short-volume cache. Latest 2026-10-21.
| Date | Short | Total | Short % |
|---|---|---|---|
| 2026-10-21 | 140,749 | 230,815 | 61.0% |
| 2026-10-20 | 121,155 | 199,336 | 60.8% |
| 2026-10-19 | 236,386 | 468,915 | 50.4% |
| 2026-10-16 | 132,649 | 330,070 | 40.2% |
| 2026-10-15 | 115,048 | 243,988 | 47.2% |
| 2026-10-14 | 195,059 | 519,097 | 37.6% |
| 2026-10-13 | 191,255 | 288,894 | 66.2% |
| 2026-10-12 | 110,188 | 203,151 | 54.2% |
| 2026-10-09 | 131,768 | 339,188 | 38.8% |
| 2026-10-08 | 726,828 | 1,050,101 | 69.2% |
URGN short volume FAQ
What was URGN's latest FINRA short volume?
On Oct 21, 2026, cached FINRA short volume for UroGen Pharma Ltd (URGN) was 140,749 shares, 61.0% of 230,815 total volume.
How many URGN short-volume sessions are listed on this page?
This page lists 10 cached FINRA short-volume sessions for UroGen Pharma Ltd (URGN), from Oct 8, 2026 through Oct 21, 2026.
How did URGN short volume percent change from the prior cached session?
Cached FINRA short volume for UroGen Pharma Ltd (URGN) moved from 60.8% on Oct 20, 2026 to 61.0% on Oct 21, 2026, up 0.2 percentage points.
What was the highest URGN short volume percent on this page?
The highest cached FINRA short volume on this page is 69.2% of total volume on Oct 8, 2026.
Where is URGN listed?
UroGen Pharma Ltd (URGN) common stock is listed on NASDAQ.
What is URGN's latest revenue?
Latest cached UroGen Pharma Ltd (URGN) revenue for Dec 31, 2025 was $109.8M. Statements: https://lician.com/financials/urgn
What is the average URGN short volume percent on this page?
Across 10 cached sessions on this page, UroGen Pharma Ltd (URGN) short volume averaged 52.6% of total volume.
Where is URGN short volume listed?
Cached FINRA short volume for UroGen Pharma Ltd (URGN) is listed at https://lician.com/short-interest/urgn.
Not investment advice. Cached rows, not a live tape.